Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 24% ± 7% |
Insufficient scRNA-seq data for expression of METTL2A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 536.93 | 459 / 459 | 100% | 15.91 | 1118 / 1118 |
esophagus | 100% | 585.24 | 1445 / 1445 | 100% | 10.87 | 183 / 183 |
liver | 100% | 456.90 | 226 / 226 | 100% | 7.65 | 406 / 406 |
ovary | 100% | 469.88 | 180 / 180 | 100% | 10.91 | 430 / 430 |
pancreas | 100% | 390.17 | 328 / 328 | 100% | 8.50 | 178 / 178 |
prostate | 100% | 521.48 | 245 / 245 | 100% | 10.93 | 502 / 502 |
stomach | 100% | 496.59 | 359 / 359 | 100% | 11.43 | 286 / 286 |
brain | 100% | 521.06 | 2640 / 2642 | 100% | 17.26 | 705 / 705 |
lung | 100% | 497.74 | 577 / 578 | 100% | 12.54 | 1155 / 1155 |
intestine | 100% | 598.38 | 966 / 966 | 100% | 11.79 | 526 / 527 |
bladder | 100% | 532.81 | 21 / 21 | 100% | 12.35 | 503 / 504 |
uterus | 100% | 518.72 | 170 / 170 | 100% | 12.62 | 458 / 459 |
thymus | 100% | 500.35 | 653 / 653 | 100% | 9.16 | 603 / 605 |
kidney | 100% | 484.57 | 89 / 89 | 100% | 9.19 | 898 / 901 |
skin | 100% | 746.52 | 1809 / 1809 | 100% | 11.89 | 470 / 472 |
adrenal gland | 100% | 709.87 | 258 / 258 | 98% | 7.63 | 226 / 230 |
adipose | 100% | 523.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.33 | 29 / 29 |
spleen | 100% | 466.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.08 | 1 / 1 |
blood vessel | 100% | 483.64 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 504.35 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 503.50 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 7.16 | 76 / 80 |
peripheral blood | 75% | 375.53 | 701 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006399 | Biological process | tRNA metabolic process |
GO_0006400 | Biological process | tRNA modification |
GO_0030488 | Biological process | tRNA methylation |
GO_0005737 | Cellular component | cytoplasm |
GO_0052735 | Molecular function | tRNA (cytidine-3-)-methyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | METTL2A |
Protein name | tRNA N(3)-methylcytidine methyltransferase (EC 2.1.1.-) tRNA N(3)-methylcytidine methyltransferase METTL2A (EC 2.1.1.-) (Methyltransferase-like protein 2A) |
Synonyms | HSPC266 METTL2 |
Description | FUNCTION: S-adenosyl-L-methionine-dependent methyltransferase that mediates N(3)-methylcytidine modification of residue 32 of the tRNA anticodon loop of tRNA(Thr)(UGU) and tRNA(Arg)(CCU) . N(3)-methylcytidine methylation by METTL2A requires the N6-threonylcarbamoylation of tRNA (t6A37) by the EKC/KEOPS complex as prerequisite . . FUNCTION: S-adenosyl-L-methionine-dependent methyltransferase. . |
Accessions | ENST00000311506.10 [Q96IZ6-1] Q96IZ6 ENST00000616852.1 A0A087WW35 |